Compared to those without SAO, patients who developed SAO had significantly higher blood levels of mucin-1 and lower DLCO at baseline; an even higher baseline mucin-1 level was observed in patients who developed early SAO (Figure 2b,c, and Supplementary Table S3). The gene discussed is MUC1; the disease is southeast Asian ovalocytosis.